Clinical trial
Quality Of Life Assessment In AD Patients Receiving Aricept Tablets (Donepezil Hydrochloride)
NCT01089582 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quality Of Life Assessment In AD Patients Receiving Aricept Tablets (Donepezil Hydrochloride)
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- July 31, 2009
- Enrollment
- 628 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.